Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

Cited by (351)

Items 101–200 of 351

1. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration
   Nichols, Charles D., Garcia, Efrain E., Sanders-Bush, Elaine · 2003 · Molecular Brain Research
2. Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists
   James Winslow, Thomas R. Insel · 1991 · Psychopharmacology
3. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors
   Pascale Mazzola‐Pomietto, Charanjit S. Aulakh, Kinga Woźniak, James Hill, Dennis L. Murphy · 1995 · Psychopharmacology
4. Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans?
   Hemmie H.G. Berendsen · 1995 · Pharmacology & Therapeutics
5. NBOMes–Highly Potent and Toxic Alternatives of LSD
   Jolanta Barbara Zawilska, Monika Kacela, Piotr Adamowicz · 2020 · Frontiers in Neuroscience
6. The Paradox of 5-Methoxy-N,N-Dimethyltryptamine
   Jerrold C. Winter, Robyn A. Filipink, D. M. Timineri, Scott Helsley, R.A. Rabin · 2000 · Pharmacology Biochemistry and Behavior
7. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)
   Patrick M. Callahan, Kathryn A. Cunningham · 1994 · European Journal of Pharmacology
8. Neuropharmacology of 5-hydroxytryptamine1B/D receptor ligands
   Philippe Chopin, Chantal Moret, Mike Briley · 1994 · Pharmacology & Therapeutics
9. Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium
   Bonson, Katherine R., Murphy, Dennis L. · 1995 · Behavioural Brain Research
10. Structure‐Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Drugs?a
    David E. Nichols, Robert A. Oberlender · 1990 · Annals of the New York Academy of Sciences
11. Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents
    Richard A. Glennon, Nissar A. Darmani, Billy R. Martin · 1991 · Life Sciences
12. Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases
    Ruud P. W. Litjens, Tibor M. Brunt, Gerard J. Alderliefste, Remco H.S. Westerink · 2014 · European Neuropsychopharmacology
13. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function
    Amy J. Eshleman, Michael J. Forster, Katherine M. Wolfrum, Robert A. Johnson, Aaron J. Janowsky, Michael B. Gatch · 2013 · Psychopharmacology
14. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors
    Jonathan C. Gewirtz, Andrew C. H. Chen, Rose Z. Terwilliger, Ronald C Duman, Gerard J. Marek · 2002 · Pharmacology Biochemistry and Behavior
15. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives
    David J. Fiorella, R.A. Rabin, Jerrold C. Winter · 1995 · Psychopharmacology
16. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor
    Adam L. Halberstadt, Mark A. Geyer · 2009 · Psychopharmacology
17. Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats
    T. F. Meert, Patrick De Haes, Paul A. J. Janssen · 1989 · Psychopharmacology
18. Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation
    Sanket B. Raut, Padmaja Anil Marathe, Liza van Eijk, Rajaraman D. Eri, Manoj Ravindran, David M. Benedek, Robert J. Ursano, Juan J. Canales, Luke R. Johnson · 2022 · Pharmacology & Therapeutics
19. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity
    E Bull, Peter H. Hutson, Kevin C.F. Fone · 2003 · Neuropharmacology
20. Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics
    Dino Luethi, Matthias E. Liechti · 2018 · The International Journal of Neuropsychopharmacology
21. Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinoginic drugs
    Elaine Sanders‐Bush, Marsha Breeding · 1991 · Psychopharmacology
22. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (‘Blue Mystic’)
    Fabrizio Schifano, Paolo Deluca, Lisa Agosti, Giovanni Martinotti, John Corkery · 2005 · Journal of Psychopharmacology
23. Clinical Features and Management of Intoxication Due to Hallucinogenic Drugs
    Jerrold Blair Leikin, Anne J. Krantz, Michele Zell‐Kanter, Robert L. Barkin, Daniel O. Hryhorczuk · 1989 · Drug Safety
24. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons
    Darrell A. Jackson, S.R. White · 1990 · Neuropharmacology
25. Serotonin receptors and their ligands: A lack of selective agents
    Richard A. Glennon, Maƚgorzata Dukat · 1991 · Pharmacology Biochemistry and Behavior
26. A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A
    Kevin Joseph Tidgewell, Wayne Wesley Harding, Mark S. Schmidt, Kenneth G. Holden, Daryl J. Murry, Thomas Edward Prisinzano · 2004 · Bioorganic & Medicinal Chemistry Letters
27. Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches
    Joshua T. Kantrowitz · 2020 · CNS Drugs
28. Irving Page Lecture: 5-HT2A serotonin receptor biology: Interacting proteins, kinases and paradoxical regulation
    Bryan L. Roth · 2011 · Neuropharmacology
29. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action
    Danuta Marona‐Lewicka, David E. Nichols · 2007 · Pharmacology Biochemistry and Behavior
30. Depletion of brain serotonin differently affects behaviors induced by 5HT1A, 5HT1C, and 5HT2 receptor activation in rats
    Hemmie H.G. Berendsen, Chris L.E. Broekkamp, Anton M. L. Van Delft · 1991 · Behavioral and Neural Biology
31. Salvinicins A and B, New Neoclerodane Diterpenes from Salvia divinorum
    Wayne Wesley Harding, Kevin Joseph Tidgewell, Matthew D. Schmidt, Kushal Shah, Christina M. Dersch, John Snyder, Damon A. Parrish, Jeffrey R. Deschamps, Richard B. Rothman, Thomas Edward Prisinzano · 2005 · Organic Letters
32. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex
    Gresch, Paul J, Smith, Randy L, Barrett, Robert J, Sanders-Bush, Elaine · 2005 · Neuropsychopharmacology
33. In vivo modulation of 5‐hydroxytryptamine release in mouse prefrontal cortex by local 5‐HT2A receptors: effect of antipsychotic drugs
    Analı́a A Bortolozzi, Mercè Amargós‐Bosch, Albert Adell, Lorenzo Díaz-Mataix, Jordi Serrats, Sebastián Pons, Francesc Artigas · 2003 · European Journal of Neuroscience
34. Characterization of the Discriminative Stimulus Properties Induced by 5‐HT1and 5‐HT2Agonists in Rats
    Jørn Arnt · 1989 · Pharmacology & Toxicology
35. 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders
    Tiago Mestre, Mateusz Zurowski, Susan Helen Fox · 2013 · Expert Opinion on Investigational Drugs
36. Detection of 5‐hydroxytryptamine 2 receptors by radioligand binding, northern blot analysis, and Ca 2+ responses in rat primary astrocyte cultures
    Darlene C. Deecher, B D Wilcox, Vijendra Dave, P. A. Rossman, Harold K. Kimelberg · 1993 · Journal of Neuroscience Research
37. Potential Role of 5HT1C and/or 5HT2 Receptors in the Mianserin‐Induced Prevention of Anxiogenic Behaviors Occurring During Ethanol Withdrawal
    Harbans Lal, Paul L. Prather, Shohreh M. Rezazadeh · 1993 · Alcoholism Clinical and Experimental Research
38. Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens
    Susan M. Mittman, Mark A. Geyer · 1989 · Psychopharmacology
39. 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens
    Richard A. Rabin, Meredith J. Regina, Mireille Doat, Jerrold C. Winter · 2002 · Pharmacology Biochemistry and Behavior
40. The 5-HT2 Receptor Activation Enhances Impulsive Responding Without Increasing Motor Activity in Rats
    Tiina Koskinen, Sirja Ruotsalainen, Jouni Sirviö · 2000 · Pharmacology Biochemistry and Behavior
41. Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor
    Halberstadt, Adam L., Nichols, David E., Geyer, Mark A. · 2012 · Psychopharmacology
42. A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs
    Marco Solmi, Chaomei Chen, Charles Dauré, Anne Buot, Michael Ljuslin, Vincent Verroust, Luc Mallet, Yasser Khazaal, Stéphane Rothen, Gabriel Thorens et al. · 2022 · European Neuropsychopharmacology
43. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice
    Bríd Á. Nic Dhonnchadha, Martine Hascoët, Pascale Jolliet, Michel Bourin · 2003 · Behavioural Brain Research
44. Involvement of 5-HT2A/2B/2C Receptors on Memory Formation: Simple Agonism, Antagonism, or Inverse Agonism?
    Alfredo Meneses · 2002 · Cellular and Molecular Neurobiology
45. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release
    Junji Ichikawa, Jin Dai, Herbert Y. Meltzer · 2001 · Brain Research
46. Agonist-Directed Signaling of Serotonin 5-HT2C Receptors Differences Between Serotonin and Lysergic Acid Diethylamide (LSD)
    J Backstrom · 1999 · Neuropsychopharmacology
47. Diversity and Bias through Receptor–Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization
    Kjell Fuxé, Alexander O. Tarakanov, Wilber Romero‐Fernandez, Luca Ferraro, Sergio Tanganelli, Małgorzata Filip, Luigi F. Agnati, Pere Garriga, Zaida Dı́az-Cabiale, Dasiel O. Borroto‐Escuela · 2014 · Frontiers in Endocrinology
48. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives
    Carla Pallavicini, Martina G. Vilas, Mirta Fabiana Villarreal, Federico Zamberlán, Suresh D Muthukumaraswamy, David Nutt, Robin Lester Carhart-Harris, Enzo Tagliazucchi · 2019 · NeuroImage
49. [125I]-2-(2,5-Dimethoxy-4-Iodophenyl) aminoethane ([125I]-2C-I) as a label for the 5-HT2 receptor in rat frontal cortex
    Michael P. Johnson, Chester A. Mathis, Alexander T. Shulgin, Andrew J. Hoffman, David E. Nichols · 1990 · Pharmacology Biochemistry and Behavior
50. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats
    F. Jenck, Chris L.E. Broekkamp, Anton M. L. Van Delft · 1990 · Psychopharmacology
51. Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane in Rhesus Monkeys
    Jun‐Xu Li, Kenner C. Rice, Charles Patrick France · 2007 · Journal of Pharmacology and Experimental Therapeutics
52. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs III: the mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion
    David J. Fiorella, Scott Helsley, Daniel S. Lorrain, R.A. Rabin, Jerrold C. Winter · 1995 · Psychopharmacology
53. Serotonin enhances excitability and gamma frequency temporal integration in mouse prefrontal fast-spiking interneurons
    Athilingam, Jegath C, Ben-Shalom, Roy, Keeshen, Caroline M, Sohal, Vikaas S, Bender, Kevin J · 2017 · eLife
54. Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice
    Adam L. Halberstadt, Susan B. Powell, Mark A. Geyer · 2013 · Neuropharmacology
55. Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)
    Dino Luethi, Daniel Trachsel, Marius Christian Hoener, Matthias E. Liechti · 2017 · Neuropharmacology
56. Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol
    Susan M. Mittman, Mark A. Geyer · 1991 · Psychopharmacology
57. Recent developments in the pharmacotherapy of substance abuse.
    Charles P. O'Brien · 1996 · Journal of Consulting and Clinical Psychology
58. Pimavanserin for the treatment of Parkinson's disease psychosis
    Joseph H. Friedman · 2013 · Expert Opinion on Pharmacotherapy
59. Stimulus properties of arylpiperazines: NAN‐190, a potential 5‐HT1A serotonin antagonist
    Richard A. Glennon, Noreen A. Naiman, M. Edward Pierson, Bryan R. Misenheimer, J. L. Herndon, Milt Titeler, Lyon Ra · 1989 · Drug Development Research
60. Toxicology and Analysis of Psychoactive Tryptamines
    Sara Malaca, Alfredo Fabrizio Lo Faro, Alice Tamborra, Simona Pichini, Francesco Paolo Busardò, Marilyn Ann Huestis · 2020 · International Journal of Molecular Sciences
61. Functional and biochemical evidence for altered serotonergic function in the Fawn-Hooded rat strain
    Charanjit S. Aulakh, Teresa J. Tolliver, Kinga Woźniak, James Hill, Dennis L. Murphy · 1994 · Pharmacology Biochemistry and Behavior
62. Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions
    Nissar A. Darmani, Billy R. Martin, Usha Pandey, Richard A. Glennon · 1990 · Pharmacology Biochemistry and Behavior
63. Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats
    D. Wei, I.M. Maisonneuve, Martin E. Kuehne, S.D. Glick · 1998 · Brain Research
64. LSD has high efficacy relative to serotonin in enhancing the cationic current Ih: Intracellular studies in rat facial motoneurons
    Jennifer C. Garratt, Meenakshi Alreja, George K. Aghajanian · 1993 · Synapse
65. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors
    Adam L. Halberstadt, Mahálah R. Buell, Virginia L. Masten, Victoria B. Risbrough, Mark A. Geyer · 2008 · Psychopharmacology
66. Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
    Katharina Elisabeth Grafinger, Matthias E. Liechti, Evangelia Liakoni · 2019 · British Journal of Clinical Pharmacology
67. The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex
    Lynette A. Desouza, Madhurima Benekareddy, Sashaina E. Fanibunda, Farhan Mohammad, Balaganesh Janakiraman, Utkarsha Ghai, Tamar Gur, Julie A. Blendy, Vidita A. Vaidya · 2021 · Frontiers in Molecular Neuroscience
68. The structural diversity of psychedelic drug actions revealed
    Ryan H. Gumpper, Manish Kumar Jain, Kuglae Kim, Renhong Sun, Ning Sun, Zhongli Xu, Jeffrey F. DiBerto, Brian E. Krumm, Nicholas J. Kapolka, H. Ümit Kanıskan et al. · 2025 · Nature Communications
69. α‐Adrenoceptor‐Mediated Modulation of 5‐HT2 Receptor Agonist Induced Impulsive Responding in a 5‐Choice Serial Reaction Time Task
    Tiina Koskinen, Antti Haapalinna, Jouni Sirvi� · 2003 · Pharmacology & Toxicology
70. Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents
    Alaina M. Jaster, Harrison Elder, Samuel A. Marsh, Mario de la Fuente Revenga, Sidney Stevens Negus, Javier González‐Maeso · 2022 · Psychopharmacology
71. Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol
    Janice M. Hitchcock, Sarah Lister, Thierry R Fischer, Joseph G. Wettstein · 1997 · Behavioural Brain Research
72. Serotonin–Glutamate Interactions A New Target for Antipsychotic Drugs
    George K. Aghajanian · 1999 · Neuropsychopharmacology
73. Role of 5-HT1A and 5-HT7 receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation
    Alfredo Meneses, José A. Terrón · 2001 · Behavioural Brain Research
74. Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.
    Cumming, Paul, Scheidegger, Milan, Dornbierer, Dario, Palner, Mikael, Quednow, Boris B., Martin-Soelch, Chantal · 2021 · Molecules
75. A discrimmative stimulus produced by l-(3-Chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety
    Cleatus J. Wallis, Harbans Lal · 1998 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
76. Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG)
    Wilfried Dimpfel, M. Sp�ler, David E. Nichols · 1989 · Psychopharmacology
77. Amperozide and emotional behaviour
    B. Gustafsson, Erik Christensson · 1990 · Pharmacology & Toxicology
78. A new approach for studying GPCR dimers: Drug-induced inactivation and reactivation to reveal GPCR dimer function in vitro, in primary culture, and in vivo
    Milt Teitler, Michael T. Klein · 2011 · Pharmacology & Therapeutics
79. The 5-HT2A Receptor (5-HT2AR) Regulates Impulsive Action and Cocaine Cue Reactivity in Male Sprague-Dawley Rats
    Dennis J. Sholler, Sonja J. Stutz, Robert G. Fox, Edward L. Boone, Qin Wang, Kenner C. Rice, Frederick Gerard Moeller, Noelle C. Anastasio, Kathryn A. Cunningham · 2018 · Journal of Pharmacology and Experimental Therapeutics
80. Bioactive Alkaloids of Hallucinogenic Mushrooms
    Piotr Paweł Wieczorek, Danuta Witkowska, Іzabela Jasicka-Misiak, Anna Poliwoda, Milena Oterman, Katarzyna Zielińska · 2015 · Studies in natural products chemistry
81. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazine
    J. L. Herndon, M. Edward Pierson, Richard A. Glennon · 1992 · Pharmacology Biochemistry and Behavior
82. Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action
    Gerard J. Marek, George K. Aghajanian · 1998 · Drug and Alcohol Dependence
83. Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses
    J. Frank Nash, Herbert Y. Meltzer, Gary A. Gudelsky · 1989 · Pharmacology Biochemistry and Behavior
84. Evidence thatm-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors
    Pascale Mazzola‐Pomietto, Charanjit S. Aulakh, Kinga Woźniak, Dennis L. Murphy · 1996 · Psychopharmacology
85. Effects of 5‐HT2A receptor stimulation on economic demand for fentanyl after intermittent and continuous access self‐administration in male rats
    David Alexander Martin, Utsav Gyawali, Donna J. Calu · 2020 · Addiction Biology
86. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice
    Michael A. Benneyworth, Randy L. Smith, Robert J. Barrett, Elaine Sanders‐Bush · 2005 · Psychopharmacology
87. The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2− and not a 5-HT1C-mediated phenomenon
    Nissar A. Darmani, Orin B. Mock, Lex C. Towns, C Gerdes · 1994 · Pharmacology Biochemistry and Behavior
88. 5-HT2A receptor antagonists inhibit potassium-stimulated γ-aminobutyric acid release in rat frontal cortex
    Nicholas V. Cozzi, David E. Nichols · 1996 · European Journal of Pharmacology
89. Lack of Cross-Tolerance for Hypophagia Induced by DOI versus m-CPP Suggests Separate Mediation by 5-HT2A and 5-HT2C Receptors, Respectively
    Charanjit S. Aulakh, Pascale Mazzola‐Pomietto, Bridgett A Hulihan-Giblin, Dennis L. Murphy · 1995 · Neuropsychopharmacology
90. Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test–retest paradigm in mice
    Nadège Ripoll, Martine Hascoët, Michel Bourin · 2005 · Behavioural Brain Research
91. Adenosine preferentially suppresses serotonin2A receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex
    Grace E. Stutzmann, Gerard J. Marek, George K. Aghajanian · 2001 · Neuroscience
92. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo
    Hans Nissbrandt, Nicholas Waters, Stephan Hjorth · 1992 · Naunyn-Schmiedeberg s Archives of Pharmacology
93. Effects of LSD, Ritanserin, 8-OH-DPAT, and Lisuride on Classical Conditioning in the Rabbit
    Scott Welsh · 1998 · Pharmacology Biochemistry and Behavior
94. Further studies on N-methyl-1(3, 4-methylenedioxyphenyl)-2-aminopropane as a discriminative stimulus: Antagonism by 5-hydroxytryptamine3 antagonists
    Richard A. Glennon, Rodney Higgs, Richard Young, Hassan Issa · 1992 · Pharmacology Biochemistry and Behavior
95. Study of the in vitro and in vivo metabolism of the tryptamine 5‐MeO‐MiPT using human liver microsomes and real case samples
    Katharina Elisabeth Grafinger, Marianne Hädener, Stefan König, Wolfgang Weinmann · 2017 · Drug Testing and Analysis
96. 5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: A comparative study using in vivo microdialysis
    Takashi Matsumoto, Yoshitaka Maeno, H. Kato, Yoshimi Seko‐Nakamura, Jun Monma-Ohtaki, Atsushi Ishiba, Masataka Nagao, Y. Aoki · 2014 · European Neuropsychopharmacology
97. A peripheral 5-HT1D-like receptor involved in serotonergic induced hindlimb scratching in rats
    Hemmie H.G. Berendsen, Chris L.E. Broekkamp · 1991 · European Journal of Pharmacology
98. Effect of serotonin depletion on 5-HT2A-mediated learning in the rabbit: evidence for constitutive activity of the 5-HT2A receptor in vivo
    Anthony G. Romano, Jennifer L. Quinn, R. Liu, Kuldip D. Dave, D. Schwab, Guillermo M. Alexander, Vincent J. Aloyo, J A Harvey · 2005 · Psychopharmacology
99. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test–retest paradigm in mice
    K.S. Gomes, Ricardo Luiz Nunes‐de‐Souza · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
100. Comparative potencies of 3,4‐methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5‐HT transport in mammalian cell lines
     Therese Montgomery, Christophe Buon, S Eibauer, Patrick J. Guiry, ALAN K. KEENAN, Gethin J. McBean · 2007 · British Journal of Pharmacology